Wanjia Asset Management Co.,Ltd - Hk Connect Innovative Drug ETF (SHA:520700)
1.695
+0.005 (0.30%)
At close: Sep 23, 2026
SHA:520700 Holdings Information
SHA:520700 is an equity ETF with a total of 44 individual holdings. The top holdings are WuXi Biologics stock at 10.58%, Innovent Biologics at 10.09%, BeOne Medicines AG at 9.70%, WuXi AppTec at 8.33%, and Akeso at 7.10%.
Total Holdings
44
Top 10 Percentage
70.32%
Asset Class
Equity
ETF Category
Health Care
Assets
730.99M
PE Ratio
18.74
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 10.58% |
| 2 | HKG: 1801 | Innovent Biologics, Inc. | 10.09% |
| 3 | HKG: 6160 | BeOne Medicines AG | 9.70% |
| 4 | HKG: 2359 | WuXi AppTec Co., Ltd. | 8.33% |
| 5 | HKG: 9926 | Akeso, Inc. | 7.10% |
| 6 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 6.16% |
| 7 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 5.90% |
| 8 | HKG: 1177 | Sino Biopharmaceutical Limited | 5.42% |
| 9 | HKG: 1530 | 3SBio Inc. | 3.76% |
| 10 | HKG: 6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 3.27% |
| 11 | HKG: 2268 | WuXi XDC Cayman Inc. | 3.15% |
| 12 | HKG: 2228 | XtalPi Holdings Limited | 2.89% |
| 13 | HKG: 1548 | Genscript Biotech Corporation | 2.05% |
| 14 | HKG: 9969 | InnoCare Pharma Limited | 1.94% |
| 15 | HKG: 2162 | Keymed Biosciences Inc. | 1.85% |
| 16 | HKG: 9688 | Zai Lab Limited | 1.80% |
| 17 | HKG: 9995 | RemeGen Co., Ltd. | 1.70% |
| 18 | HKG: 0867 | China Medical System Holdings Limited | 1.65% |
| 19 | JNGHF | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 1.15% |
| 20 | HKG: 0013 | HUTCHMED (China) Limited | 1.12% |
| 21 | HKG: 2096 | Simcere Pharmaceutical Group Limited | 1.11% |
| 22 | HKG: 6855 | Ascentage Pharma Group International | 1.08% |
| 23 | HKG: 2196 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 0.90% |
| 24 | HKG: 1952 | Everest Medicines Limited | 0.76% |
| 25 | HKG: 0512 | Grand Pharmaceutical Group Limited | 0.73% |
As of Jun 30, 2026